Squillace N, Ricci E, Menzaghi B, De Socio GV, Passerini S, Martinelli C, . . . Bonfanti P. (2020). The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile. Dove Medical Press.
Chicago Style (17th ed.) CitationSquillace N, et al. The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile. Dove Medical Press, 2020.
MLA (9th ed.) CitationSquillace N, et al. The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.